Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review
Go back to Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review| Aethlon Medical, Inc. (NASDAQ: AEMD) | Delayed: 1.37 -0.01 (0.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.38 | 52 Week High | $9.09 | |||
| Open | $1.38 | 52 Week Low | $4.02 | |||
| Day High | $1.43 | P/E | N/A | |||
| Day Low | $1.35 | EPS | $-0.05 | |||
| Volume | 125,985 | |||||
